FDA Adverse Event Malfunction Summary report: N

DIMENSION(R) CLINICAL CHEMISTRY SYSTEM

MDR report key: 4142673 · Received October 6, 2014

Report

Report Number
2517506-2014-00228
Event Type
Malfunction
Date Received
October 6, 2014
Date of Event
May 21, 2014
Report Date
September 15, 2014
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
Product Code
LCP
PMA / PMN Number
K102510
Removal / Correction Number
2517506-10-03-2014-008-C
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

SIEMENS HEALTHCARE DIAGNOSTICS HAS CONFIRMED THAT THE DIMENSION® HB1C FLEX® REAGENT CARTRIDGE LOTS GA4266, BA4273, BA4280, BA4287, GA4301, GA4315, GC4322, GA4343, GA4350, GA4357, GA5013, AND GA5020 EXHIBIT A POSITIVE BIAS AVERAGING 0.4% HEMOGLOBIN A1C UNITS AND OCCASIONALLY UP TO 1.0% HBA1C UNITS FOR PATIENT SAMPLES WHEN COMPARED TO THE (B)(6). QC SAMPLES MAY EXHIBIT A SIMILAR BIAS. THIS BIAS RESULTED IN COMPLAINTS FOR (B)(6) SURVEY FAILURES. IN THE URGENT MEDICAL DEVICE RECALL LETTER DATED SEPTEMBER 2014, (B)(4) ISSUED TO CUSTOMERS WHO WERE SHIPPED THE IMPACTED LOTS, SIEMENS DIRECTED CUSTOMERS TO DISCONTINUE USE AND TO DISCARD THE IMPACTED LOTS. SIEMENS STATED IT WOULD REPLACE ANY UNUSED INVENTORY OF THE AFFECTED LOTS AT NO CHARGE WITH A NON-AFFECTED LOT.

Description of Event or Problem · 1

BIASED HIGH HB1C RESULTS WERE OBTAINED ON COLLEGE OF (B)(6) SAMPLES. IT IS UNKNOWN IF PATIENT TREATMENT WAS ALTERED OR PRESCRIBED ON THE BASIS OF THE BIASED HIGH HB1C RESULTS. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THE BIASED HIGH HB1C RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
623017 DIMENSION(R) CLINICAL CHEMISTRY SYSTEM HEMOGLOBIN A1C KIT LCP SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW GA4315

Patients

Seq Age Sex Outcome Treatment
1 Disability